Researchers at the Leonard Wolfson Experimental Neurology Centre in London, UK, want to accelerate early-stage treatment trials for neurodegenerative disorders. Dara Mohammadi speaks to the investigators about the need to stimulate drug discovery.
Over 150 people in Montgomery are set to gather this weekend to reclaim the future for the five millions Americans suffering from Alzheimer’s. For two women in the River Region, the disease has directly impacted their lives and they’re leading the fight for a cure.
Finding ways to diagnose and treat this devastating disease has frustrated scientists and clinicians ever since. Now the long and hard-fought campaign against Alzheimer’s has reached a potentially significant milestone: the launch of the first clinical trials to test whether new drug treatments given before dementia can prevent the disease.
